Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC).

Saved in:
Bibliographic Details
Title: Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): A phase II study (NIRA-PANC).
Authors: Kasi A; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Al-Rajabi RMT; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Baranda JC; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Saeed A; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Dai J; University of Kansas Medical Center, Department of Biostatistics and Data Science, Kansas City, KS, USA 66160., Chalise P; University of Kansas Medical Center, Department of Biostatistics and Data Science, Kansas City, KS, USA 66160., Weir S; Department of Toxicology, Pharmacology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA 66160., Sear B; Department of Toxicology, Pharmacology and Therapeutics, University of Kansas Medical Center, Kansas City, KS, USA 66160., Carroll E; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Bradbury S; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Tripathi A; University of Kansas Medical Center, Department of Internal Medicine, Kansas City, KS, USA 66160., Hyter S; University of Kansas Medical Center, Department of Pathology and Laboratory Medicine, Kansas City, KS, 66160., Beeki V; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., McKittrick RJ; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160., Kumer S; University of Kansas Medical Center, Department of Surgery, Kansas City, KS, USA 66160., Schmitt T; University of Kansas Medical Center, Department of Surgery, Kansas City, KS, USA 66160., Soper S; University of Kansas Medical Center, School of Biomedical Engineering, Kansas City, KS, USA 66160., Godwin AK; University of Kansas Medical Center, Department of Internal Medicine, Kansas City, KS, USA 66160., Sun W; University of Kansas Medical Center, Department of Medical Oncology, Kansas City, KS, USA 66160.
Source: The oncologist [Oncologist] 2026 Jun 05. Date of Electronic Publication: 2026 Jun 05.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1549-490X
DOI:10.1093/oncolo/oyag225